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ABSTRACT
The skin is a squamous epithelium that is continuously renewed by a
population of basal layer stem/progenitor cells and can heal wounds.
Here, we show that the transcription regulators YAP and TAZ localise
to the nucleus in the basal layer of skin and are elevated upon wound
healing. Skin-specific deletion of both YAP and TAZ in adult mice
slows proliferation of basal layer cells, leads to hair loss and impairs
regeneration after wounding. Contact with the basal extracellular
matrix and consequent integrin-Src signalling is a key determinant
of the nuclear localisation of YAP/TAZ in basal layer cells and in
skin tumours. Contact with the basement membrane is lost in
differentiating daughter cells, where YAP and TAZ become mostly
cytoplasmic. In other types of squamous epithelia and squamous cell
carcinomas, a similar control mechanism is present. By contrast,
columnar epithelia differentiate an apical domain that recruits CRB3,
Merlin (also known as NF2), KIBRA (also known as WWC1) and
SAV1 to induce Hippo signalling and retain YAP/TAZ in the cytoplasm
despite contact with the basal layer extracellular matrix. When
columnar epithelial tumours lose their apical domain and become
invasive, YAP/TAZ becomes nuclear and tumour growth becomes
sensitive to the Src inhibitor Dasatinib.
KEYWORDS: Hippo pathway, Integrin, Yes-associated protein, TAZ,
Stratified squamous epithelium
INTRODUCTION
The Yes-associated protein (YAP) family of transcriptional co-
activators are emerging as potent oncoproteins that strongly drive
cell proliferation in many types of stem/progenitor cells and cancers
(Harvey et al., 2013; Irvine and Harvey, 2015; Pan, 2010, 2015;
Piccolo et al., 2013). The function of YAP family co-activators was
first discovered by Drosophila genetics, where the sole YAP
homologue Yorkie (Yki) was found to be necessary and sufficient to
promote cell proliferation and tissue overgrowth in epithelia (Huang
et al., 2005). Subsequent genetic experiments in mice showed that
ectopic expression of YAP (also known as YAP1) was sufficient to
drive cell proliferation in liver, intestine, bronchus and skin (Cai
et al., 2010; Camargo et al., 2007; Dong et al., 2007; Schlegelmilch
et al., 2011; Zhang et al., 2011a; Zhao et al., 2014). Surprisingly,
YAP knockout mice have mild phenotypes, although they are
deficient in proliferative repair of the intestine and resistant to
intestinal tumour formation (Azzolin et al., 2014; Cai et al., 2010),
as well as showing reduced bronchial stem cells (Zhao et al., 2014)
and kidney defects (Reginensi et al., 2015). An important and
widespread physiological role for YAP in mice might be obscured
by the possibility of redundancy between YAP and TAZ (also
known as WWTR1) a second mammalian family member that is
highly similar in both sequence and function.
At the molecular level, Yki and YAP were shown to function by
associating with the DNA-binding transcription factor Scalloped
(Sd; or TEAD in humans) to drive transcription of anti-apoptotic
and pro-proliferative target genes (Koontz et al., 2013; Liu-
Chittenden et al., 2012; Vassilev et al., 2001; Wu et al., 2008).
Other co-factors of Yki/YAP that promote transcription include
WBP2 (Zhang et al., 2011b), MASK1/2 (Sansores-Garcia et al.,
2013; Sidor et al., 2013) and the SWI/SNF complex (Jin et al., 2013;
Oh et al., 2013). The activity of Yki was found to be regulated by the
Drosophila Hippo-Warts (Hpo-Wts) kinase signalling pathway, in
which Wts directly phosphorylates Yki to promote its relocalisation
from the nucleus to the cytoplasm (Dong et al., 2007; Huang
et al., 2005; Oh and Irvine, 2008). In human cells in culture, YAP
nuclear localisation is similarly inhibited upon LATS1/2 kinase
phosphorylation, because phosphorylated YAP is retained the
cytoplasm by binding to 14-3-3 family proteins (Dong et al., 2007;
Zhao et al., 2007). This entire molecular system is now referred to as
the Hippo signalling pathway.
Much recent work has aimed to identify upstream regulators of
Hippo signalling. A group of apically localised proteins including
Crumbs (Crb, CRB1/2/3 in humans), Merlin (Mer, NF2 in humans),
Expanded (Ex, similar to Willin and AMOT in humans) and Kibra
(Kib, KIBRA or WWC1 in humans) were found to activate Hippo
signalling (repressing Yki activity) in Drosophila epithelia
(Baumgartner et al., 2010; Chen et al., 2010; Genevet et al.,
2010; Hamaratoglu et al., 2006; Ling et al., 2010; Varelas et al.,
2010; Yu et al., 2010) and in mice (Szymaniak et al., 2015). In
addition, a group of adherens junction-localised proteins including
Ajuba (Jub), Zyxin (Zyx), Dachs, Mib and Riquiqui (Riq), were
shown to inhibit Hippo signalling (activating Yki) in Drosophila
epithelia (Cho et al., 2006; Das Thakur et al., 2010; Degoutin et al.,
2013; Gaspar et al., 2015; Mao et al., 2006; Rauskolb et al., 2011).
Finally, manipulation of the level of F-actin in Drosophila can also
affect Hippo signalling, possibly via signalling through the Src
kinase, which can promote Yki activation (Enomoto and Igaki,
2013; Fernandez et al., 2011, 2014; Sansores-Garcia et al., 2011).
Human YAP and TAZ were subsequently found to act as F-actin
responsive mechanosensors in cell culture (Aragona et al., 2013;
Benham-Pyle et al., 2015; Dupont et al., 2011; Zhao et al., 2007),Received 3 December 2015; Accepted 9 March 2016
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but how their subcellular localisation is physiologically regulated in
human epithelial tissues and cancers in vivo remains a fundamental
unsolved problem.
Here, we examine the physiological function and regulation of
YAP and TAZ in mammalian epithelial tissues. We focus on
stratified squamous epithelia, particularly the skin, and compare our
findings with columnar epithelia, such as the intestine and bronchus.
We propose that YAP and TAZ act as sensors of both apical and
basal signals in vivo, and that this regulatory logic explains why
these proteins localise to the nucleus in basal stem/progenitor cells
to promote cell proliferation and tissue renewal. Elevation of YAP
and TAZ can then drive increased cell proliferation during wound
healing or tumour formation.
RESULTS
YAP and TAZ are expressed in both mouse and human skin,
and regulate gene expression in basal layer stem/progenitor
cells
We began by characterising the expression and subcellular
localisation of YAP and TAZ in both mouse and human skin.
Both proteins were found to be expressed and nuclear localised in a
subset of cells in the skin of the mouse embryo, neonate and adult.
Nuclear localisation of YAP and TAZ was particularly prominent in
basal layer cells of both interfollicular epidermis and the hair follicle
(Fig. 1A). Some nuclear localisation was also detected in the highly
flattened squamous cells, consistent with results in cell culture
where cell flattening induces nuclear accumulation of YAP and TAZ
(Dupont et al., 2011) (Fig. 1A). Human YAP and TAZ show a
similar pattern of subcellular localisation in sections of adult human
skin (Fig. 1B). Basal layer cells feature nuclear YAP and TAZ,
whereas differentiating daughters feature cytoplasmic YAP and
TAZ (Fig. 1B). Again, some nuclear localisation is also detectable
in highly flattened squamous cells that have terminally
differentiated (Fig. 1B).
To confirm that YAP and TAZ are transcriptionally active in
the skin, we sought to identify YAP-regulated genes by an RNA-
sequencing (RNA-seq) approach in human keratinocytes. mRNA
was isolated from cells expressing activated mutant YAP5SA or
siRNAs against YAP and subjected to RNA-seq and gene-set
enrichment analysis (Fig. 1C, Fig. S1). We found that the YAP-
regulated gene sets included: the previously identified Hippo/
YAP reactomes; cell cycle reactomes (such as E2F targets or
cyclin E-associated genes); cell growth reactomes (such as Myc,
global translation regulators or regulation of ornithine
Fig. 1. YAP and TAZ are expressed in both mouse and human skin and regulate gene expression in basal layer stem cells. (A) Mouse skin at three
developmental stages, including embryonic (E17.5), neonate and adult. Tissue sections were stained for either YAP or TAZ to reveal their expression and
subcellular localisation. (B) Human skin (adult) stained for either YAPor TAZ. Note the nuclear localisation in basal layer stem/progenitor cells as well as terminally
differentiating flattened cells. Other differentiating cells have cytoplasmic YAPand TAZ localisation. Arrows indicate nuclear YAP/TAZ; asterisks indicate flattened
suprabasal cells with nuclear YAP/TAZ. (C) Analysis of YAP-dependent gene expression by RNA-seq was performed by comparison of YAP gain and loss of
function in keratinocytes (see Fig. S1). (D) YAP-regulated genes identified by RNA-seq analysed for their expression patterns in skin tissue by mining the Human
Protein Atlas dataset (see Materials and Methods). Strong enrichment in basal layer stem/progenitor cells is evident for many target genes, indicating that YAP
and TAZ are transcriptionally active in this population of cells.
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decarboxylase); cancer signalling reactomes (such as EGFR-Ras
signalling targets); and cancer microenvironment/metastasis
reactomes (including regulators of cellular interactions with the
extracellular matrix) (Fig. S1). We therefore analysed the
expression of the corresponding cell cycle [CycE1 (CCNE2),
PCNA, E2F1], cell growth [RPTOR, ODC1, ADC (AZIN2)]
and EGFR and integrin signalling (CYR61, CTGF, AREG,
integrins α3, α6, β1, β2, β4) regulators (Fig. 1D). We found a
striking restriction of these YAP targets to the basal layer of
the skin, indicating that YAP/TAZ transcriptional regulation is
active exclusively in the basal stem/progenitor cell population
(Fig. 1D).
YAP and TAZ are required for skin homeostasis
To examine the physiological role of YAP and TAZ, we generated
double conditional knockout (dKO) mice with the skin-specific
Keratin5-CreERT recombinase. Compared with control animals, the
YAP/TAZ dKO mice showed a dramatic loss of hair in patches
beginning 2 weeks after tamoxifen injection in adult mice, or
causing complete blockade of hair growth in neonates treated with
tamoxifen (Fig. 2A,B). Histological sections of the skin revealed
expression and nuclear localisation of YAP and TAZ in control skin,
which was lost in the dKO tissue. Proliferation of basal layer cells, as
marked by Ki67 staining, was clearly reduced in YAP/TAZ dKO
skin (Fig. 2A,B), as was YAP target gene expression (Fig. S2).
These phenotypes are reminiscent of skin-specific conditional
knockouts of integrin β1 (ITGB1) (Brakebusch et al., 2000; Grose
et al., 2002; Piwko-Czuchra et al., 2009; Raghavan et al., 2000;
Singh et al., 2009).
We next tested whether YAP and TAZ contribute to skin repair
after wounding. We found that levels of both YAP and TAZ were
elevated after wounding, particularly in the basal cell layer of the
epidermis where strong nuclear staining is visible (Fig. 2C,D). We
next recorded the time taken to repair small (4 mm) wounds in the
back skin of control versus YAP/TAZ dKO mice. We found that
control wounds normally healed completely by 10 days, whereas
dKO wounds failed to heal within 10 days and instead required an
additional 2 days to heal (Fig. 2E,F). This delay in healing was not
observed when YAP or TAZ were deleted individually. To
investigate the cause of the delay in wound healing, we examined
Fig. 2. Conditional inactivation of YAPand TAZ impairs skin homeostasis andwound repair inmice. (A) Control mice have a thick layer of hair (fur) covering
their skin, which sections reveal is positive for YAP, TAZ and Ki67 (a marker of cell proliferation). (B) Double conditional knockout mice for YAP and TAZ
treated with tamoxifen as adults or neonates exhibit dramatic hair loss. Adult skin sections are negative for YAP and TAZ, and have reduced levels of Ki67+
positive cells (quantified as a percentage of total interfollicular basal cells in each randomly selected 40× field of view. n=757 control cells; n=896 dKO cells).
(C) Control mouse skin stained for YAP and TAZ. (D) Punch biopsy wound edge stained for YAP and TAZ. (E) Imaging of wound healing in control (n=8) and YAP/
TAZ double conditional knockout mice (dKO; n=8). Note delayed healing in dKO. (F) Quantification of wound healing rates in control versus dKO animals. ImageJ
was used tomeasure thewound area at each stage. (G) Proliferation of cells asmarked by Ki67 staining is reduced in dKOwounds versus control animals. Values
are means±s.e.m. *P<0.05, **P<0.01.
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cell proliferation in wounds of control versus dKO mice. We
found that the number of Ki67+ cells was reduced in dKO wounds
versus controls (Fig. 2G). These findings demonstrate a crucial,
physiological requirement for YAP and TAZ in basal layer stem/
progenitor cells to promote cell proliferation.
In the skin of the ITGB1 conditional knockout mice, cells that
escape Cre-mediated recombination are able to repopulate themutant
skin in a short time frame (Piwko-Czuchra et al., 2009). We found
that the same phenomenon occurs in YAP/TAZ dKO skin, where
after Cre activation and YAP/TAZ deletion, either YAP+ or TAZ+
residual cells expanded their territory, consistent with the notion that
YAP and TAZ promote proliferation of basal layer cells (Fig. S3).
This phenomenon was also evident during wound healing, where
YAP or TAZ positive cells were able to populate the wound and
allow proliferation and healing in dKO animals (Fig. S3). These
findings underscore the importance of YAP and TAZ in epidermal
progenitor cell proliferation and skin homeostasis and suggest a close
relationship between integrin signalling and YAP/TAZ function.
Mechanisms controlling nuclear localisation of YAP in basal
layer cells
We next sought to understand how YAP and TAZ become nuclear
localised in basal layer cells. Since YAP and TAZ are similar
proteins that localise identically in skin, we henceforth focus on the
regulation of YAP localisation. Recent work in cultured MCF10A
breast cancer cells indicate a role for integrin-Src signalling and
EGFR-PI3K signalling in promoting the nuclear localisation of
YAP (Fan et al., 2013; Kim and Gumbiner, 2015). To test whether
these pathways are active in skin, we examined their expression and
subcellular localisation. By mining the Human Protein Atlas
dataset, we found that ITGB1, SRC, EGFR and AKT2 (a marker
of PI3K activation) are all expressed strongly in basal layer cells,
with AKT2 recruited to the interface between basal layer epidermal
cells and the underlying basement membrane extracellular matrix
(Fig. 3A-E). This pattern is also evident in other squamous epithelia
such as cervix or oesophagus and is retained in squamous cell
carcinomas (Fig. 3A-E). These data suggest that nuclear YAP
localisation might be stimulated by integrin-Src and/or PI3K
signalling in basal layer skin keratinocytes (Fig. 3F).
To confirm that integrin-Src and PI3K signalling pathways
are required for YAP nuclear localisation in keratinocytes, we
systematically manipulated these pathways with siRNA knockdown
or treatment with specific inhibitor compounds in human
keratinocytes in culture. We found that inhibition of ITGB1 with
blocking antibodies or siRNA, inhibition of the downstream
effectors SRC or FAK, or inhibition of PI3K profoundly impairs
Fig. 3. Integrin-Src and EGFR-PI3K localisation in human stratified squamous epithelia and squamous cell carcinomas (SSCs). The Human Protein
Atlas dataset was mined to compare the expression and localisation of potential YAP regulators in human skin sections. YAP staining reveals basal layer nuclear
localisation (A), ITGB1, SRC and EGFR staining reveals basal layer expression (B-D) and AKT2 staining reveals basal subcellular localisation (E) across
squamous tissue types and cancers. (F) Model for YAP regulation in stratified squamous epithelia.
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YAP nuclear localisation (Fig. 4A,B). Interestingly, inhibition of
the PI3K effectors AKT and TORC1 had no effect on YAP
localisation, whereas inhibition of PDK1 did partially impair YAP
nuclear localisation (Fig. 4C). Notably, drugs inhibiting F-actin,
myosin II or Rho kinase had only a moderate effect on YAP
localisation in keratinocytes (Fig. 4D). Quantification of these
phenotypes highlights the strong effect of inhibition of integrin-Src
and PI3K (Fig. 4E). Both Src inhibitors and PI3K inhibitors led to a
clear increase in phosphorylated YAP (p-YAP), indicating that
Hippo signalling (MST-LATS signalling) is elevated by these
treatments (Fig. 4F). We confirmed these findings in a classic
‘scratch-wound’ assay, where Src inhibition completely reversed
the nuclear localisation of YAP at the leading edge (Fig. 4G). These
findings indicate that integrin-Src and EGFR-PI3K signalling are
essential for YAP nuclear localisation in keratinocytes (Fig. 4H).
To extend these findings in vivo, we examined the role of
integrin-Src signalling in mouse skin. We compared YAP
localisation in untreated and TPA-treated (inflamed) skin samples
from control animals and knockouts for FAK or Src (Fig. 5A-C).We
found that loss of FAK or Src results in decreased YAP levels and
nuclear localisation in both normal and inflamed skin (Fig. 5A-C).
Some nuclear YAP remained in flattened cells (Fig. 5A-C,
asterisks). Similar results were obtained by treatment of mice with
the topical Src inhibitor (Dasatinib), which was able to drastically
reduce YAP levels and nuclear localisation in untreated or TPA-
treated skin, as well as in skin papillomas induced by a TPA
+DMBA treatment regimen (Fig. 5D-I). These findings show that
integrin-Src signalling is crucial to promote YAP stabilisation and
nuclear localisation in basal layer stem/progenitor cells.
Accordingly, recent work indicates that skin papillomas induced
by DMBA+TPA in mice can be strongly reduced in size and
frequency by homozygous deletion of YAP along with one copy of
TAZ or by treatment with Dasatinib (Creedon and Brunton, 2012;
Serrels et al., 2009; Zanconato et al., 2015).
Fig. 4. Basal integrin-Src signalling promotes nuclear localisation of YAP in human HaCaT keratinocyte epithelial cells. (A) YAP nuclear localisation is
prevented by treatment of keratinocytes with anti-ITGB1 antibodies (PD52) or by ITGB1 siRNA treatment. (B) YAP nuclear localisation is prevented by treatment
of keratinocytes with the Src inhibitor Dasatinib, by the FAK inhibitor PF573228 or by the PI3K inhibitor GDC0941, but not by treatment with DMSO solvent.
(C) YAP nuclear localisation is reduced by treatment of keratinocytes with the PDK1 inhibitor BX795, but not by the AKT inhibitor MK2206, TORC1 inhibitor
Everolimus or DMSO solvent. (D) YAP nuclear localisation is reduced by treatment of keratinocytes with the F-actin destabilising drug Latrunculin, the myosin II
inhibitor Blebbistatin, or the Rho-kinase inhibitor Y27632. (E) Quantification of A-D. (F) Western blotting analysis of p-YAP levels in keratinocytes treated with
either DMSO control, PI3K inhibitor or Src inhibitor. Total YAP levels are shown as a control. (G) Nuclear YAP localisation at the leading edge of a scratch wound in
keratinocyte culture is abolished by treatment with the Src inhibitor Dasatinib. (H) Schematic diagram of YAP regulation in keratinocytes.
1678
STEM CELLS AND REGENERATION Development (2016) 143, 1674-1687 doi:10.1242/dev.133728
D
E
V
E
LO
P
M
E
N
T
Mechanisms controlling YAP cytoplasmic localisation
in differentiating daughter cells of squamous versus
columnar epithelia
The above analysis suggests that daughter cells differentiate in the
skin simply by loss of contact with the basement membrane
extracellular matrix and consequent loss of integrin-Src signalling,
EGFR-PI3K signalling and YAP nuclear localisation. This model is
plausible in all stratified squamous epithelia, but cannot explain the
self-renewal versus differentiation decision in columnar epithelia
because differentiated columnar epithelial cells retain contact with
the basement membrane. Thus, columnar cells must employ an
additionalmechanism to promote YAP localisation to the cytoplasm.
An obvious candidate is the expression of a differentiated apical
plasma membrane domain in columnar epithelial cells, because
apical proteins associated with Crumbs (CRB3) are well known to
induceHippo signalling (MST-LATS signalling) to drive YAP to the
cytoplasm (Chen et al., 2010; Fletcher et al., 2015; Ling et al., 2010;
Szymaniak et al., 2015; Varelas et al., 2010).
To test this notion in vivo, we compared the subcellular
localisation of YAP with that of CRB3 in columnar epithelia in
the gallbladder, endometrium, lung bronchus, breast duct, urinary
bladder, small intestine, colon and salivary gland. In all cases, apical
localisation of CRB3 in differentiated daughter cells correlated with
cytoplasmic localisation of YAP (Fig. 6A-H). Accordingly, basal
layer stem/progenitor cells of the lung, breast or intestine retained
nuclear YAP but lack apical CRB3. Notably, CRB3 is not expressed
in squamous epithelia so cannot mediate the regulation of YAP in
these tissues (Fig. 6I-L). The key Hippo pathway components
Merlin, SAV1 and KIBRA colocalised with CRB3 (Figs S4 and S5)
(Chen et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006;
Ling et al., 2010; Yin et al., 2013; Yu et al., 2010; Zhang et al.,
2010). These results indicate that a universal regulatory logic exists
Fig. 5. Basal integrin-Src signalling promotes YAP stability and nuclear localisation in mouse skin. (A) YAP staining in control and TPA-treated skin
to induce hyperplasia. (B) YAP staining is reduced in FAK conditional KO skin before or after treatment with TPA. Note some residual nuclear YAP
localisation in basal layer cells or highly flattened cells (asterisk). (C) YAP staining is reduced in Src conditional KO skin before or after treatment with TPA. Note
that there is some residual nuclear YAP localisation in basal layer cells or highly flattened cells (asterisks). (D) YAP staining is reduced in Dasatinib-treated skin
before or after treatment with TPA for 2 days. Note there is some residual nuclear YAP localisation in basal layer cells or highly flattened cells (asterisk). (E) YAP
staining of mouse skin papilloma induced by DMBA-TPA treatment of mice expressing v-Ha-Ras (see Materials and Methods). Note stronger nuclear
localisation in the basal layer. (F) YAP staining of mouse skin squamous cell carcinoma induced by DMBA-TPA treatment of v-Ha-Ras-expressing mice. (G) YAP
staining is strongly reduced by treatment of DMBA-TPA induced papillomas with the Src inhibitor Dasatinib topically for 3 days. (H) Quantification of nuclear
YAP intensity in A-D. (I) Quantification of nuclear YAP intensity in F,G. Values are means±s.e.m.
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in which YAP nuclear localisation requires contact with the
basement membrane but is inhibited by expression of an apical
domain (Fig. 6M).
We next sought to confirm that apical and basal signals act
antagonistically in columnar epithelial cells. We examined human
intestinal epithelial cells in culture that are capable of forming 3D
cysts or 2D monolayers in which YAP becomes cytoplasmic.
We found that siRNA knockdown of the apical determinant
CDC42 or LATS1/2 has similar effects, driving YAP to the
nucleus (Fig. 7A,B). Strong YAP nuclear localisation can also be
achieved simply by plating these cells at low density, so that they
are unable to differentiate an apical domain and also retain a flat
morphology with an extensive basal surface area (Fig. 7C). This
basal contact appears to invoke the same integrin-Src signals
identified in keratinocytes, because blocking of integrins with low
Ca2+, anti-ITGB1 antibodies or ITGB1 siRNAs relocalised YAP to
the cytoplasm (Fig. 7C). Inhibition of Src, FAK, PI3K or PDK1
also impaired YAP nuclear localisation (Fig. 7D,E). These effects
are once again as strong as inhibition of F-actin, myosin II or Rho
kinase (Fig. 7F,G). Examination of p-YAP levels indicated that
integrin-Src signalling acts via regulation of MST-LATS
phosphorylation of YAP (Fig. 7H). These results suggest that
apical domain formation activates LATS kinases to retain YAP in
the cytoplasm, whereas basal integrin-Src and PI3K signalling
inhibits LATS kinases to promote nuclear YAP localisation
(Fig. 7I).
To further explore these findings in vivo, we examined how YAP
behaves in columnar epithelial tumours that progress to invasive
adenocarcinomas. We found that YAP remains cytoplasmic
whereas tumours of the colon, stomach, lung, endometrium,
urothelium or ovary retained their columnar epithelial form
(Fig. 8A-F). By contrast, invasive adenocarcinomas of the same
Fig. 6. Apical-domain formation inhibits YAP nuclear localisation in human columnar epithelia. The Human Protein Atlas dataset was mined to
compare the localisation of YAP with the presence of absence of the apical domain in different epithelia. YAP localises to the cytoplasm in columnar gallbladder
epithelium (A) and columnar endometrial epithelium (B) which have a CRB3+ apical domain. (C) YAP localises to the nucleus of basal layer stem/progenitors,
which lack CRB3 expression, and cytoplasm in columnar epithelial cells, which have a CRB3+ apical domain, in the bronchus. (D) YAP localises to the nucleus of
basal layer stem/progenitors, which lack CRB3 expression, and cytoplasm in columnar epithelial cells, with a CRB3+ apical domain, in the breast. (E) YAP
localises to the cytoplasm in pseudostratified columnar bladder epithelium, with a CRB3+ apical domain. (F) YAP localises to the nucleus of crypt base stem/
progenitors, which lack a large CRB3+ apical domain, and cytoplasm in columnar epithelial cells, which feature a large CRB3+ apical domain, in the small
intestine. (G) YAP localises to the nucleus of crypt base stem/progenitors, which have a small CRB3+ apical domain, and cytoplasm in columnar epithelial cells,
which feature a large CRB3+ apical domain, in the colon. (H) YAP localises to the nucleus of basal layer stem/progenitors, which lack CRB3 expression, and
cytoplasm in columnar epithelial cells, which have aCRB3+ apical domain, in the salivary gland. (I-L) YAP localises to the nucleus of basal layer stem/progenitors,
and cytoplasm of differentiating squamous epithelial cells, even though the entire tissue lacks CRB3 expression. (M) Schematic diagram of YAP localisation in
different epithelial tissue types.
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tissue origin all featured a loss of columnar form and a dramatic
localisation of YAP to the nucleus (Fig. 8A-F). These results
suggest that loss of the apical domain during tumour progression
allows YAP to become nuclear. We therefore tested whether nuclear
YAP in invasive adenocarcinomas would be sensitive to inhibition
of integrin-Src signalling with Dasatinib. We examined Apc−/− p53
(Trp53)−/− mutant intestinal organoids that had been implanted
subcutaneously into nude mice. On transplantation, these organoids
rapidly produce highly invasive adenocarcinomas, entering the
surrounding stromal tissue. We found that YAP localisation became
strongly nuclear, specifically in the invasive tumour cells (Fig. 8G).
We next treated mice carrying such invasive tumours with the Src
inhibitor Dasatinib, which strongly suppressed nuclear YAP
localisation and reduced tumour growth and invasion (Fig. 8H).
These findings indicate that Src activity promotes YAP nuclear
localisation in vivo and suggest a potential therapy for invasive
adenocarcinomas and carcinomas.
DISCUSSION
Our results identify a physiological role for YAP and TAZ in skin
homeostasis, promoting cell proliferation in basal layer stem/
progenitor cells (Figs 1, 2). YAP and TAZ localise to the nucleus of
basal layer cells to drive transcription of a set of genes associated
with cell cycle progression, cell growth, EGFR signalling and cell-
matrix adhesion via integrins. In the absence of YAP and TAZ,
proliferation is reduced and dramatic hair loss occurs, indicating that
YAP and TAZ are crucial players in the stem/progenitor cell biology
of the skin. Importantly, loss of either YAP or TAZ individually had
Fig. 7. Basal integrin-Src signalling promotes YAP nuclear localisation in human Caco2 epithelial cells when apical domain formation is blocked.
(A) Caco2 colon adenocarcinoma cells form 3D cysts in cell culture that feature cytoplasmic YAP localisation. Silencing of CDC42 by siRNA knockdown disrupts
apical-basal polarity and induces more nuclear YAP localisation. (B) Caco2 colon adenocarcinoma cells form 2D epithelial monolayers at high density. Silencing
of CDC42 by siRNA knockdown disrupts apical-basal polarity and induces more nuclear YAP localisation, similar to silencing of LATS1/2. (C) YAP nuclear
localisation is very strong when Caco2 cells are plated at low density to prevent apical domain formation. Nuclear localisation is prevented by treatment of Caco2
cells with low-calcium medium, anti-ITGB1 antibodies (PD52) or by ITGB1 siRNA treatment, but not in controls. (D) YAP nuclear localisation is prevented by
treatment of Caco2 cells with the Src inhibitor Dasatinib, by the FAK inhibitor PF573228 or by the PI3K inhibitor GDC0941, but not by treatment with DMSO
solvent. (E) YAP nuclear localisation is reduced by treatment of Caco2 cells with the PDK1 inhibitor BX795, but not by the AKT inhibitor MK2206, TORC1 inhibitor
Everolimus or DMSO solvent. (F) YAP nuclear localisation is reduced by treatment of Caco2 cells with the F-actin destabilising drug Latrunculin, the myosin II
inhibitor Blebbistatin or the Rho kinase inhibitor Y27632, or a combination of Blebbistatin and Y27532. (G) Quantification of C-F. (H) Western blotting analysis of
p-YAP levels in Caco2 cells treated with control siRNAs or ITGB1 siRNAs, as well as DMSO control, FAK inhibitor, PI3K inhibitor or Src inhibitor. Total YAP levels
are shown as a control. (I) Schematic diagram of YAP regulation in Caco2 cells.
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no visible phenotype, confirming that the two proteins act in a
redundant fashion in this tissue.
Both YAP and TAZ localise to the nucleus in the basal layer cells
of the skin and we focused on YAP to characterize the molecular
mechanisms responsible for this nuclear localisation (Figs 3–5). We
examined the model that integrin-Src and EGFR-PI3K signalling
promotes YAP nuclear localisation, which was first proposed based
on experiments in MCF10A breast cells in culture (Fan et al., 2013;
Kim and Gumbiner, 2015), and found that these signalling
molecules are indeed strongly expressed in basal layer skin cells
and are essential to promote YAP nuclear localisation in
keratinocytes in culture and in mouse basal layer skin cells
in vivo. Since YAP appears to induce expression of integrins,
integrin ligands (CYR61, CTGF) and EGFR ligands (AREG), we
propose that a positive feedback loop drives basal layer stem/
progenitor cell identity and that this loop is broken when daughter
cells lose contact with the basement membrane and differentiate –
forming a bistable system of cell fate determination. Our findings
provide an explanation for how these signalling pathways integrate
to control skin stem/progenitor cell biology.
The notion that nuclear localisation of YAP occurs upon contact
with basement membrane extracellular matrix applies equally to
other squamous epithelia. By contrast, columnar epithelia
differentiate an apical domain that induces YAP relocalisation to
the cytoplasm via apical CRB3-MER-KIBRA-SAV signals, which
are known to activate the MST and LATS kinases to promote YAP
phosphorylation and cytoplasmic retention despite contact with the
basement membrane (Figs 6, 7, Figs S4-S6) (Baumgartner et al.,
2010; Chen et al., 2010; Fletcher et al., 2015; Genevet et al., 2010;
Hamaratoglu et al., 2006; Ling et al., 2010; Sun et al., 2015;
Szymaniak et al., 2015; Varelas et al., 2010; Yin et al., 2013; Yu
et al., 2010). The CRB3-MER-KIBRA-SAV complex appears to be
Fig. 8. YAP becomes nuclear in invasive adenocarcinomas, which become sensitive to Dasatinib. In the colon (A) and stomach (B) YAP localises to the
cytoplasm of columnar epithelial cells in epithelial adenocarcinoma, and the nucleus of invasive adenocarcinoma cells, which have lost their columnar shape and
lack a lumen. (C) In the bronchus, YAP localises to the nucleus of basal layer stem/progenitors and cytoplasm in columnar epithelial cells in epithelial
adenocarcinoma, and the nucleus of invasive adenocarcinoma. (D) In the endometrial epithelium, YAP localises to the cytoplasm of columnar epithelial cells in
epithelial adenocarcinoma, and the nucleus of invasive adenocarcinoma cells. (E) In urothelial epithelium, YAP localises to the cytoplasm in pseudostratified
columnar cells in epithelial adenocarcinoma and to the nucleus of invasive adenocarcinoma. (F) YAP localises to the cytoplasm in ovarian adenocarcinoma, and
to the nucleus of invasive ovarian adenocarcinoma. (G) YAP staining in Apc−/− p53−/− tumour organoids implanted subcutaneously into nude mice, which invade
dramatically into the surrounding tissue. Note that cells at the invasive front feature nuclear YAP localisation, whereas columnar epithelial cells in the central
regions of the tumour feature cytoplasmic YAP localisation. (H) YAP staining is strongly reduced by Dasatinib treatment of Apc−/− p53−/− tumour organoids
implanted subcutaneously into nude mice. Invasive tumour cells are not visible. Quantification of YAP nuclear localisation was performed on n=200 tumour cells
from G and H. Values are means±s.e.m.
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absent in squamous epithelia, which never differentiate a true apical
domain, leaving basement membrane contact as the sole regulatory
mechanism (Fig. 6). Thus, our results show that antagonistic apical
and basal polarity signals serve as the primary control mechanism
that determines YAP subcellular localisation in vivo. In a striking
parallel, the same apical and basal polarity determinants act
antagonistically in epithelial membrane polarisation, with integrin
and PI3K signalling localising PtdIns(3,4,5)P3 basally, and helping
to restrict and/or orient PtdIns(4,5)P2, CDC42 and the CRB3
complex apically (Akhtar and Streuli, 2013; Bryant et al., 2014;
Fletcher et al., 2012; Martin-Belmonte et al., 2007; Thompson,
2013). Further work will be necessary to fully elaborate the
molecular interactions that mediate the antagonistic relationship
between apical and basal signals in cell polarisation and nuclear
signalling via YAP.
This fundamental control mechanism appears to be conserved
across the animal kingdom. For example, Drosophila simple
columnar epithelia such as imaginal discs rely primarily on apical
Crb-Mer/Ex-Kibra-Sav signalling to retain Yki in the cytoplasm and
restrict tissue growth (Baumgartner et al., 2010; Chen et al., 2010;
Genevet et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Yu
et al., 2010). By contrast, Drosophila stratified columnar epithelia
such as the intestine require integrins, Src, EGFR andYki to promote
proliferation of basal layer stem/progenitor cells, suggesting that the
regulatory connection between them described here is also conserved
(Cordero et al., 2014; Jiang et al., 2011; Kohlmaier et al., 2015; Lin
et al., 2013; Shaw et al., 2010; Staley and Irvine, 2010; Xu et al.,
2011). Furthermore, ectopic activation of Src, EGFR, PI3K or Yki in
simple columnar imaginal discs is sufficient to induce
overproliferation of cells, whereas loss of PI3K or Yki strongly
impairs imaginal disc tumour formation (Doggett et al., 2011;
Enomoto and Igaki, 2013; Fernandez et al., 2014; Herranz et al.,
2012, 2014; Strassburger et al., 2012; Willecke et al., 2011).
Our model raises interesting questions about the possible
physiological roles of other YAP regulators identified in cell
culture, namely that YAP is controlled by Wnt signalling (Azzolin
et al., 2014; Cai et al., 2015; Park et al., 2015), GPCR signalling
(Yu et al., 2012), PKA signalling (Yu et al., 2013), LKB1-MARK
signalling (Mohseni et al., 2014), protease-activated receptors
(Mo et al., 2012) or the Mevalonate pathway (Sorrentino et al.,
2014). Further work is necessary to understand in which tissues
and under what conditions these diverse signals are utilised and
integrated in vivo.
Importantly, our model is easily reconciled with a possible role
of YAP as a mechanosensor in epithelial tissues in vivo (Dupont
et al., 2011). Mechanical force has been proposed to modulate
signalling by both the apical Crb-Mer/Ex-Kibra-Sav system in
Drosophila (Fletcher et al., 2015; Rauskolb et al., 2014) as well
as the basal integrin-Src system in mammalian cell culture
(reviewed in Humphrey et al., 2014; Lawson and Burridge, 2014).
In the early mouse pre-implantation embryo, cortical tension is
higher in outer cells than inner cells, leading to nuclear YAP in
outer cells despite the presence of an apical domain (Anani et al.,
2014; Kono et al., 2014; Nishioka et al., 2009). Consistently,
reducing cortical tension with a ROCK inhibitor abolishes nuclear
localisation of YAP in early mouse embryos (Anani et al., 2014;
Kono et al., 2014; Nishioka et al., 2009). Mechanical forces
might also explain why YAP becomes nuclear in some terminally
differentiating and extremely flattened keratinocytes (Fig. 5, cells
marked by asterisk).
Finally, our model is also easily reconciled with the ability of
YAP to respond to inflammatory cues in epithelia, such as
interleukin-6 (IL-6). Recent work revealed that the IL-6 co-
receptor gp130 triggers stabilisation and nuclear translocation of
YAP via Src kinases (Taniguchi et al., 2015). This signalling
module was shown to be activated by mucosal injury to intestinal
epithelia to promote intestinal regeneration, a known Src and YAP
function (Cai et al., 2010; Cordero et al., 2014; Taniguchi et al.,
2015). We confirm that tissue damage (with 14Gy of radiation)
elevates YAP levels in a Src-dependent manner in the intestine
(Fig. S7). However, we note that upon damage, localisation of YAP
is still mostly nuclear in basal crypt stem cells, which normally lack
an apical domain, and mostly cytoplasmic in differentiated
columnar epithelial cells, which have an apical domain (Fig. S7).
Interestingly, hyperproliferation per se driven by conditional
deletion of APC and oncogenic mutation of KRAS (VillinCreER
Apcfl/fl K-rasLSL-G12D) does not change the fundamental pattern of
YAP localisation, with localisation of YAP remaining most strongly
nuclear in the basal stem cells but not the columnar epithelial
cells (Fig. S6). In the skin, YAP is also elevated upon wounding
(Fig. 2C,D) or inflammation (upon TPA treatment) in a Src-
dependent manner (Fig. 5), but remains most strongly nuclear in the
basal layer stem/progenitor cell population (Fig. 5). Thus, Src acts as
a point of convergence between inflammatory cues and apical-basal
polarity cues, with polarity cues being the dominant input. Further
work is necessary to understand whether Src acts primarily by
directly phosphorylating YAP or indirectly via enhancing PI3K
signalling to inhibit MST-LATS activity. Nevertheless, our findings
add weight to the notion that chemical inhibitors of Src kinases such
as Dasatinib are promising cancer therapeutics (Creedon and
Brunton, 2012; Karim et al., 2013) (Fig. 8).
In conclusion, epithelial stem/progenitor cell proliferation and
differentiation might be regulated primarily by apical-basal polarity
signals. In particular, YAP, a key driver of cell proliferation in stem/
progenitor cells and cancer, appears to act primarily as a sensor of
epithelial cell polarity and only secondarily as a sensor of other
stimuli. Stem/progenitor cells thus use information about their
polarity status to inform their decisions to either proliferate or arrest/
differentiate via control of YAP. In the skin epithelium, nuclear
YAP acts redundantly with TAZ to drive gene expression in the
basal stem/progenitor cell layer to maintain cell proliferation and
normal tissue homeostasis.
MATERIALS AND METHODS
Mouse strains
All experiments were carried out in accordance with the United Kingdom
Animal Scientific Procedures Act (1986) and UK Home Office regulations
under project licence number 70/7926. The Yapfl/fl Tazfl/fl mice were a gift
from Axel Behrens (Francis Crick Institute).K5-CreERtmice were obtained
from Ian Rosewell (Francis Crick Institute). v-HA-Ras transgene (TG.AC)
mice were a gift from Ilaria Malanchi (Francis Crick Institute) and have been
previously described (Leder et al., 1990). Wild-type mice were used in
mixed background. All transgenic mice were in mixed background and used
with littermate controls. APC p53 tumour sections from implanted nude
mice were obtained from Owen Sansom (The Beatson Institute). K14-Cre
Fakfl/fl mice and Srcfl/fl, Fyn−/−, Yes−/− mice were obtained from Val
Brunton (University of Edinburgh) and were described previously (Marcotte
et al., 2012; Ridgway et al., 2012). Apc−/− p53−/− (Apc580D/580D P53
Trp53Δ2−10 allele) mice were obtained from Owen Sansom and were
previously described (Jonkers et al., 2001; Shibata et al., 1997). AhCre is
previously described (Ireland et al., 2004). K-rasG12D allele is from Tyler
Jacks (Jackson et al., 2001).
siRNA treatment
Human Caco-2, A431 or HaCAT cells were cultured as previously stated
(Fletcher et al., 2015; Elbediwy et al., 2012). All siRNA transfections
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were performed using Lipofectamine RNAiMax transfection reagent
(Invitrogen). Briefly, cells were seeded in 6-well plates and treated with
the siRNA/transfection mix 2 h post seeding. A final concentration of
50-100 nM siRNA was used for transfections. The following day, another
transfection was performed before the cells were trypsinised 4 h later and
reseeded either for 2D or 3D culture. 2D siRNA treatments were left for a
total of 72 h and 3D treatments were left for a total of 120 h. 3D cultures
were prepared as previously stated (Elbediwy et al., 2012). siRNAs were
used as siGenome pools (Dharmacon).
Treatment with inhibitor, blocking antibody and low-calcium
medium
2D mammalian inhibitor treatments were for 4 h. They were as follows:
5 µM PF573228 (FAK); 5 µM Saracatinib (Src); 5 µM Dasatinib (Src/Abl);
5 µM BX795 (PDK1); 5 µM MK2206 (AKT); 2 µM GDC0941 (PI3K);
100 µM Blebbistatin (myosin); 100 µM Y27632 (Rock); 2 µM Latrunculin
A (actin) and 3 µM Everolimus (mTOR); reagents were supplied by Sigma-
Aldrich and Stratech Scientific Ltd. Integrin β1 blocking antibody or control
IgG antibody (gifts from Nancy Hogg, Francis Crick Institute) was
incubated with the cells for 1 h at a concentration of 10 µg/ml before the
cells were replated. Low-calcium conditions were as previously reported
(Elbediwy et al., 2012). 2D wound healing involved plating the cells at high
density, causing a scratch and subsequent addition of Dasatinib for 4 h.
Antibodies, image acquisition and quantification
Primary antibodies used were: rabbit YAP (H-125, Santa Cruz, sc-15407;
1:200IF, 1:1000 IB), mouse YAP (63.7; Santa Cruz, sc-101199; 1:200 IF,
1:1000 IB), rabbit p-YAP (Cell Signaling Technology, 4911; 1:1000 IB).
Samples were imaged with a Leica SP5 confocal microscope using a 63× oil
immersion objective and processed using Adobe Photoshop. Fixation and
cell culture quantification was carried out as previously described (Fletcher
et al., 2015).
YAP/TAZ conditional deletion
Tamoxifen (Sigma, 20 mg/ml in peanut oil) was injected intraperitoneally
(IP) (5 µl/g body weight) for 5 consecutive days into 8- to 16-week-old
controls or transgenic animals carrying K5-CreERt Yapfl/fl Tazfl/fl to induce
Yap/Taz knockdown and analysed for Yap/Taz deficiency by
immunohistochemistry 7 days thereafter. K5-CreERt Yapfl/fl Tazfl/fl mice
used for long-term analysis were subsequently IP injected with tamoxifen
every month for 3 consecutive days and analysed 8 weeks after the start of
tamoxifen treatment.
Wound healing
Following the 5-day tamoxifen treatment, 4 hydroxy-tamoxifen (4OHT,
Sigma) was topically applied to shaved back skin for 5 consecutive days at a
dosage of 10 mg/ml in ethanol and 100 µl was applied per mouse.Micewere
anaesthetised with IsoFlo (Isoflurane, Abbott Animal Health) and treated
with the analgesics Vetergesic (Alstoe Animal Health) and Rimadyl (Pfizer
Animal Health) for 2 days after wounding. A 4 mm punch wound was made
in the back skin using a biopsy punch (Miltex) 10 days after tamoxifen/
4OHT treatment start and wound closure monitored over time.
Dasatinib treatment of skin
Wild-type mice between 8 and 12 weeks of age were topically treated with
150 µl Dasatinib (10 µM in DMSO, Selleck) onto the shaved back skin
directly followed by 200 µl TPA (12-O-tetradecanoylphorbol-13-acetate;
stock dissolved in DMSO and diluted in acetone, 12.5 µg/mouse) treatment
for 2 consecutive days. Mice were analysed and the back skin harvested on
the third day. Control mice were treated with DMSO and acetone.
Chemical carcinogenesis
Chemical skin carcinogenesis was induced on 12-week-old v-Ha-Ras
transgene (TG.AC)-expressing mice in mixed background by a single
application of 100 µg/mouse DMBA [7,12-dimethylbenz(a)anthracene,
Sigma] onto the shaved backskin followed by biweekly topical treatments
with TPA (4 µg/mouse) starting 1 week after DMBA application. Skin
papillomas were detectable 8 weeks after start of DMBA-TPA treatment and
harvested at 13 weeks. For Dasatinib treatment, papillomas allowed to reach
∼1 cm3. These established papillomas were treated topically with Dasatinib
(10 µM in DMSO/acetone; 100 µl/papilloma) once and analysed 3 or 7 days
thereafter. For generation of skin carcinomas,∼12-week-old DMBA-treated
FVB/N wild-type mice were treated biweekly with 4 µg/mouse TPA onto
shaved back skin for 10 weeks then weekly for a further 4 weeks before the
carcinomas were harvested.
Intestinal experiments
Mice carrying the AhCre recombinase were induced by three intraperitoneal
(i.p.) injections of 80 mg/kg β-Napthoflavone for 1 day. Intestinal
phenotypes were analysed 4 or 7 days after transgene induction to assess
homeostasis or regeneration, respectively. Intestinal regeneration was
induced by irradiating mice with 14Gy gamma-irradiation 4 days after
recombinase induction. Mice were sacrificed 72 h post irradiation and the
small intestine isolated and flushed with tap water. Ten 1 cm portions of
small intestine were bound together with surgical tape and fixed in 4%
neutral buffered formalin.
Organoid transplantation experiments
Intestinal crypts from VillinCreER Apcfl/fl p53fl/fl mice were removed 4 days
following Cre induction with Tamoxifen (2 mg). This causes full
recombination at both the Apc and p53 loci and organoids now grow as
spheres in an R-Spondin-independent manner (Sato et al., 2009). For
transplantation of organoids, 50 organoids were transplanted subcutaneously
into nude mice (see Valeri et al., 2014). A dose of 10 mg/kg Dasatinib daily
gavage was chosen as we have previously shown to cause a reduction in
p-SRC in vivo without toxicity (Morton et al., 2010). Mice were treated
continuously from 10 days post injection of spheres.
Immunohistochemistry
Mouse back skin samples were harvested and fixed in neutral-buffered
formaldehyde 10% v/v and then embedded in paraffin blocks. 4-µm-thick
sections were cut, deparaffinised and rehydrated using standard methods.
After an antigen retrieval step, sections were stained with Hematoxylin and
Eosin (H&E) solution or with primary antibody. Additional images of
human samples were obtained by datamining the www.proteinatlas.org
database (Berglund et al., 2008; Lundberg and Uhlén, 2010; Pontén et al.,
2008; Uhlen et al., 2005, 2015, 2010).
RNA-seq analysis
A431 or HaCAT cell lysates transfected with empty vector, YAP1 S5A,
control siRNA or YAP1 siRNAs were used. Sequencing was performed on
biological triplicates on the Illumina HiSeq 2500 platform and generated
∼69 million 100 bp paired end reads per sample (data deposited in GEO
under accession number GSE80082). Sequenced reads were trimmed to 75
base pairs and mapped to the Refseq genome model, using RSEM
(v.1.2.21). RSEM uses the bowtie2 alignment tool. Gene counts were
filtered to remove genes with 10 or fewer mapped reads per sample. TMM
(treated mean of M-values) normalisation and differential expression
analysis using the negative binomial model was carried out with the R-
Bioconductor package ‘EdgeR’. Genes with logCPM>1 and FDR<0.05
were judged to be differentially expressed. Enrichments of pathway,
category and motif gene sets were assessed using GSEA with logFC pre-
ranked gene lists. Gene sets with an enrichment false discovery rate (FDR)
value of less than 0.05 were judged to be strongly statistically significant and
values of less than 0.25 significant.
qPCR
Total RNA was extracted from homogenised mouse skin using an RNeasy
Mini Kit (Qiagen). cDNA synthesis for WT or dKO mice was performed
using Superscript II (Invitrogen). Primers were purchased as Quantitect
Primers (Qiagen). Gene samples were run in triplicate on a Quantstudio 12
Flex Thermocycler. Expression values were calculated using the ΔΔCT
method relative to the housekeeping gene β-2-microglobulin (B2M).
All error bars indicate s.e.m.
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